Skip to main content
TipRanks
Go Ultimate75% OFF

Ronald Blanck Insider Profile

4 Followers

Ronald Blanck, Director at Tenax Therapeutics, holds 6.06K shares in Tenax Therapeutics (Ticker: TENX). Most recently, Ronald Blanck Bought 5,000 shares of Tenax Therapeutics on May 19, 2020 for an estimated value of $4.75K.

Ronald Blanck's Trading History

TENX
Tenax Therapeutics
May 19, 2020DirectorInformative Buy4.75K$8.97K
TENX
Insider Shares: 6.06K (0.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 19, 2020Informative Buy$4.75K5,000$0.95+72.40%
Dec 20, 2017Informative Buy$5.83K12,950$0.45-88.00%
Nov 20, 2017Informative Sell$5.05K12,950$0.39-15.40%
May 27, 2016Informative Buy$9.17K3,500$2.62-79.90%
Nov 19, 2015Informative Buy$6.08K1,900$3.20-52.10%

You May Also Like

Ronald Blanck insider profile FAQ

What is the percentage of profitable transactions made by Ronald Blanck?
The percentage of profitable transactions made by Ronald Blanck is 17%.
What is the average return per transaction made by Ronald Blanck?
The average return per transaction made by Ronald Blanck is -29.60%.
What stocks does Ronald Blanck hold?
Ronald Blanck holds: TENX stocks.
What was Ronald Blanck’s latest transaction?
Ronald Blanck’s latest transaction was an Informative Buy of $4.75K.
What was Ronald Blanck's most profitable transaction?
Ronald Blanck’s most profitable transaction was an Informative Buy of TENX stock on May 19, 2020. The return on the trade was 72.40%.
What is Ronald Blanck's role in Tenax Therapeutics?
Ronald Blanck's role in Tenax Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.